^
Association details:
Biomarker:No biomarker
Cancer:Burkitt Lymphoma
Drug:methotrexate (THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor)
Regimen:RICE (carboplatin + etoposide IV + ifosfamide + Rituxan (rituximab))
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Burkitt lymphoma: suggested treatment regimens…second-line therapy…other recommended regimens…RICE (rituximab, ifosfamide, carboplatin, etoposide); intrathecal methotrexate if have not received previously